Prevention and treatment of osteoporosis in women
- PMID: 36357006
- PMCID: PMC10009319
- DOI: 10.1177/20533691221139902
Prevention and treatment of osteoporosis in women
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
-
- National Institute for Health and Care Excellence . Osteoporosis; assessing the risk of clinical fracture: Clinical Guideline (CG146), 2012. Last updated February 2017. - PubMed
-
- Lufkin EG, Wahner HW, O’Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Int Med 1992; 117: 1–9. - PubMed
-
- Lees B, Stevenson JC. The prevention of osteoporosis using sequential low-dose hormone replacement therapy with estradiol-17 and dydrogesterone. Osteoporos Int 2001; 12: 251–258. - PubMed
-
- Bagger YZ, Tankó LB, Alexandersen P, et al. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study. Bone 2004; 34: 728–735. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
